Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases

Abroad (travel likely)RecruitingPHASE3

Conditions

Brain Metastases

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • University of Arizona Cancer Center-Orange Grove Campus, Tucson, Arizona, United States

    Contact: Study coordinator (Site Public Contact) · 520-694-8900
    Contact: Principal Investigator (Baldassarre Stea)
  • University of Arizona Cancer Center-North Campus, Tucson, Arizona, United States

    Contact: Study coordinator (Site Public Contact) · UACC-IIT@uacc.arizona.edu
    Contact: Principal Investigator (Baldassarre Stea)
  • City of Hope Corona, Corona, California, United States

    Contact: Study coordinator (Site Public Contact) · becomingapatient@coh.org · 626-256-4673
    Contact: Principal Investigator (Sean Szeja)
  • City of Hope Comprehensive Cancer Center, Duarte, California, United States

    Contact: Study coordinator (Site Public Contact) · becomingapatient@coh.org · 800-826-4673
    Contact: Principal Investigator (Sean Szeja)
  • City of Hope at Irvine Lennar, Irvine, California, United States

    Contact: Study coordinator (Site Public Contact) · 877-467-3411
    Contact: Principal Investigator (Sean Szeja)
  • UC San Diego Moores Cancer Center, La Jolla, California, United States

  • City of Hope Antelope Valley, Lancaster, California, United States

    Contact: Study coordinator (Site Public Contact) · becomingapatient@coh.org · 800-826-4673
    Contact: Principal Investigator (Sean Szeja)
  • UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States

  • Kaiser Permanente-Rancho Cordova Cancer Center, Rancho Cordova, California, United States

  • Rohnert Park Cancer Center, Rohnert Park, California, United States

  • The Permanente Medical Group-Roseville Radiation Oncology, Roseville, California, United States

  • South Sacramento Cancer Center, Sacramento, California, United States

  • Kaiser Permanente Medical Center - Santa Clara, Santa Clara, California, United States

  • City of Hope South Pasadena, South Pasadena, California, United States

    Contact: Study coordinator (Site Public Contact) · becomingapatient@coh.org · 800-826-4673
    Contact: Principal Investigator (Sean Szeja)
  • Kaiser Permanente Cancer Treatment Center, South San Francisco, California, United States

  • City of Hope South Bay, Torrance, California, United States

    Contact: Study coordinator (Site Public Contact) · 877-467-3411
    Contact: Principal Investigator (Sean Szeja)
  • City of Hope Upland, Upland, California, United States

    Contact: Study coordinator (Site Public Contact) · becomingapatient@coh.org · 800-826-4673
    Contact: Principal Investigator (Sean Szeja)
  • Boca Raton Regional Hospital, Boca Raton, Florida, United States

  • UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (Benjamin J. Rich)
  • UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (Benjamin J. Rich)
  • Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood, Florida, United States

  • Mayo Clinic in Florida, Jacksonville, Florida, United States

  • University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (Benjamin J. Rich)
  • Memorial Hospital West, Pembroke Pines, Florida, United States

  • UM Sylvester Comprehensive Cancer Center at Plantation, Plantation, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (Benjamin J. Rich)
  • Moffitt Cancer Center, Tampa, Florida, United States

  • Piedmont Hospital, Atlanta, Georgia, United States

  • Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States

  • Emory Saint Joseph's Hospital, Atlanta, Georgia, United States

  • Saint Alphonsus Cancer Care Center-Boise, Boise, Idaho, United States

  • Northwestern University, Chicago, Illinois, United States

  • Decatur Memorial Hospital, Decatur, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Loyola University Medical Center, Maywood, Illinois, United States

  • HSHS Saint Elizabeth's Hospital, O'Fallon, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Methodist Medical Center of Illinois, Peoria, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • OSF Saint Francis Medical Center, Peoria, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Carle Cancer Center, Urbana, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Daniel H. Barnett)
  • Northwestern Medicine Cancer Center Warrenville, Warrenville, Illinois, United States

  • Community Cancer Center North, Indianapolis, Indiana, United States

  • Iowa Methodist Medical Center, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-6727
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Luminis Health Anne Arundel Medical Center, Annapolis, Maryland, United States

  • Walter Reed National Military Medical Center, Bethesda, Maryland, United States

    Contact: Study coordinator (Site Public Contact) · 301-319-2100
    Contact: Principal Investigator (Corbin A. Helis)
  • Tufts Medical Center, Boston, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · ContactUsCancerCenter@TuftsMedicalCenter.org · 617-636-5000
    Contact: Principal Investigator (John E. Mignano)
  • University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CancerAnswerLine@med.umich.edu · 800-865-1125
    Contact: Principal Investigator (Michelle M. Kim)
  • Mayo Clinic in Rochester, Rochester, Minnesota, United States

  • Regions Hospital, Saint Paul, Minnesota, United States

  • Saint Francis Medical Center, Cape Girardeau, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · sfmc@sfmc.net · 573-334-2230
    Contact: Principal Investigator (Bryan A. Faller)
  • Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Jiayi Huang)
  • Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Jiayi Huang)
  • Washington University School of Medicine, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Jiayi Huang)
  • Siteman Cancer Center-South County, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Jiayi Huang)
  • Missouri Baptist Medical Center, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-996-5569
    Contact: Principal Investigator (Bryan A. Faller)
  • Billings Clinic Cancer Center, Billings, Montana, United States

  • Benefis Sletten Cancer Institute, Great Falls, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon, New Hampshire, United States

  • AtlantiCare Surgery Center, Egg Harbor, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 609-748-7200
    Contact: Principal Investigator (James C. Wurzer)
  • State University of New York Upstate Medical University, Syracuse, New York, United States

    Contact: Study coordinator (Site Public Contact) · 315-464-5476
    Contact: Principal Investigator (Michael D. Mix)
  • SUNY Upstate Medical Center-Community Campus, Syracuse, New York, United States

  • Mission Hospital, Asheville, North Carolina, United States

  • Cone Health Cancer Center, Greensboro, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · stacey.phelps@conehealth.com · 336-832-0836
    Contact: Principal Investigator (Sarah E. Squire)
  • East Carolina University, Greenville, North Carolina, United States

  • Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 336-713-6771
    Contact: Principal Investigator (Michael D. Chan)
  • Sanford Bismarck Medical Center, Bismarck, North Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsFargo@sanfordhealth.org · 701-323-5760
    Contact: Principal Investigator (Daniel Almquist)
  • University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States

  • Legacy Good Samaritan Hospital and Medical Center, Portland, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · cancer@lhs.org · 800-220-4937
    Contact: Principal Investigator (Andrew Y. Kee)
  • Geisinger Medical Center, Danville, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · HemonCCTrials@geisinger.edu · 570-271-5251
    Contact: Principal Investigator (Heath B. Mackley)
  • Fox Chase Cancer Center Buckingham, Furlong, Pennsylvania, United States

  • Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

  • Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · HemonCCTrials@geisinger.edu · 570-271-5251
    Contact: Principal Investigator (Heath B. Mackley)
  • Self Regional Healthcare, Greenwood, South Carolina, United States

  • Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States

  • Dartmouth Cancer Center - North, Saint Johnsbury, Vermont, United States

  • Medical College of Wisconsin, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 414-805-3666
    Contact: Principal Investigator (Michael W. Straza)
  • Arthur J E Child Comprehensive Cancer Centre, Calgary, Alberta, Canada

    Contact: Study coordinator (Site Public Contact) · ctsucontact@westat.com · 888-823-5923
    Contact: Principal Investigator (Muhammad S. Faruqi)
  • Cross Cancer Institute, Edmonton, Alberta, Canada

    Contact: Study coordinator (Site Public Contact) · 780-432-8500
    Contact: Principal Investigator (Samir I. Patel)
  • BCCA-Vancouver Cancer Centre, Vancouver, British Columbia, Canada

    Contact: Study coordinator (Site Public Contact) · 888-939-3333
    Contact: Principal Investigator (Alan M. Nichol)
  • QEII Health Sciences Centre/Nova Scotia Health Authority, Halifax, Nova Scotia, Canada

    Contact: Study coordinator (Site Public Contact) · 902-473-6000
    Contact: Principal Investigator (Michael N. Ha)
  • Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada

  • London Regional Cancer Program, London, Ontario, Canada

    Contact: Study coordinator (Site Public Contact) · 519-685-8600
    Contact: Principal Investigator (Melody Qu)
  • University Health Network-Princess Margaret Hospital, Toronto, Ontario, Canada

    Contact: Study coordinator (Site Public Contact) · clinical.trials@uhn.on.ca · 416-946-4501
    Contact: Principal Investigator (David B. Shultz)
  • CSSS Champlain-Charles Le Moyne, Greenfield Park, Quebec, Canada

  • CHUM - Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada

    Contact: Study coordinator (Site Public Contact) · info.cr.chum@ssss.gouv.qc.ca · 514-890-8000
    Contact: Principal Investigator (David Roberge)
  • The Research Institute of the McGill University Health Centre (MUHC), Montreal, Quebec, Canada

  • Jewish General Hospital, Montreal, Quebec, Canada

    Contact: Study coordinator (Site Public Contact) · 514-340-8222
    Contact: Principal Investigator (Thierry M. Muanza)
  • CHU de Quebec-L'Hotel-Dieu de Quebec (HDQ), Québec, Quebec, Canada

    Contact: Study coordinator (Site Public Contact) · rechclinique@crchuq.ulaval.ca
    Contact: Principal Investigator (Isabelle Thibault)
  • Centre Hospitalier Universitaire de Sherbrooke-Fleurimont, Sherbrooke, Quebec, Canada

Study leads
  • David Roberge

    Study Chair

    CHUM-Centre Hospitalier de l'Universite de Montreal

  • Michael Chan

    Study Chair

    Wake Forest School of Medicine, Winston-Salem, NC

  • Vina Gondi

    Study Chair

    Northwestern Medicine Cancer Center, Warrenville IL